We can't find the internet
Attempting to reconnect
25598.2 PFNM-NM
Illuneo: a non-invasive, continuous blood glucose bedside measurement for preterm infants at the neonatal intensive care unit
Résumé
Illuneo: a non-invasive, continuous blood glucose bedside measurement for preterm infants at the neonatal intensive care unit
Textes supplémentaires
Abstract
The aim is to prevent impaired brain development in extreme and very preterm neonates in addition to reducing pain, infection risks, and to lowering costs for hospitals via continuous, non-invasive, transdermal, auto-calibrating glucose monitoring with passive diffusion. We developed, patented and tested in vitro a novel measurement principle with two parallel measurements for calibrating skin resistance. We now need to prove our new principle in a clinical pilot trial.
Participants
Martin Wolf
Kontaktperson
martin.wolf@usz.ch
USZ Universitätsspital Zürich Martin Wolf Frauenklinikstrasse 10 8091 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2017-03-31
- Date de fin
- 2018-12-31
- Coûts totaux approuvés
- CHF 150000.00
- Section
- 22 Förderbereich Nano / Micro
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T171 Microelectronics 100.0%